Is Severity Score Associated With Indication for Hematopoietic Stem Cell Transplantation in Individuals With Sickle Cell Anemia? (2022)
- Authors:
- USP affiliated authors: SABINO, ESTER CERDEIRA - FM ; ROCHA, VANDERSON GERALDO - FM
- Unidade: FM
- DOI: 10.1016/j.jtct.2022.06.024
- Subjects: EXPERIÊNCIAS DE VIDA; ANEMIA FALCIFORME; ESTUDOS MULTICÊNTRICOS
- Language: Inglês
- Imprenta:
- Source:
- Título: Transplantation and cellular therapy
- ISSN: 2666-6375
- Volume/Número/Paginação/Ano: v. 28, n. 10, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
V, Miriam Flor-Park et al. Is Severity Score Associated With Indication for Hematopoietic Stem Cell Transplantation in Individuals With Sickle Cell Anemia?. Transplantation and cellular therapy, v. 28, n. 10, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50541. Acesso em: 18 fev. 2026. -
APA
V, M. F. -P., Ozahata, M. C., Moura, I. C. G., Blatyta, P., Kelly, S., Oliveira, C. D. L., et al. (2022). Is Severity Score Associated With Indication for Hematopoietic Stem Cell Transplantation in Individuals With Sickle Cell Anemia? Transplantation and cellular therapy, 28( 10). doi:10.1016/j.jtct.2022.06.024 -
NLM
V MF-P, Ozahata MC, Moura ICG, Blatyta P, Kelly S, Oliveira CDL, Capuani L, Belisario AR, Carneiro-proietti ABF, Araujo AS, Sabino EC, Rocha VG. Is Severity Score Associated With Indication for Hematopoietic Stem Cell Transplantation in Individuals With Sickle Cell Anemia? [Internet]. Transplantation and cellular therapy. 2022 ; 28( 10):[citado 2026 fev. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50541 -
Vancouver
V MF-P, Ozahata MC, Moura ICG, Blatyta P, Kelly S, Oliveira CDL, Capuani L, Belisario AR, Carneiro-proietti ABF, Araujo AS, Sabino EC, Rocha VG. Is Severity Score Associated With Indication for Hematopoietic Stem Cell Transplantation in Individuals With Sickle Cell Anemia? [Internet]. Transplantation and cellular therapy. 2022 ; 28( 10):[citado 2026 fev. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50541 - Identification and Characterization of Hematopoietic Stem Cell Transplant Candidates in a Sickle Cell Disease Cohort
- Prevalence and laboratorial determinants of the clinical relevance of antibodies of undetermined specificity
- Effectiveness of strategies to screen for blood donors with RH variants in a mixed population
- SMIM1 intron 2 gene variations leading to variability in Vel antigen expression among Brazilian blood donors
- High frequency of variant RHD genotypes among donors and patients of mixed origin with serologic weak-D phenotype
- -318C/T polymorphism of the CTLA-4 gene is an independent risk factor for RBC alloimmunization among sickle cell disease patients
- Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing
- RHD and RHCE genotyping by next-generation sequencing is an effective strategy to identify molecular variants within sickle cell disease patients
- Comparison of characteristics and laboratory tests of COVID-19 hematological patients from France and Brazil during the pre-vaccination period: identification of prognostic profiles for survival
- Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe
Informações sobre o DOI: 10.1016/j.jtct.2022.06.024 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
